Brief: PCI Biotech Q3 operating loss widens to NOK 9.4 million

PCI Biotech Holding ASA

17/11/2015 07:01

Nov 17 (Reuters) - PCI Biotech Holding ASA  PCIB.OL : 
    * Q3 operating loss 9.4 million Norwegian crowns ($1.1 million) versus loss 
8.4 million crowns year ago 
    * Q3 pre-tax loss 9.3 million crowns versus loss 8.3 million crowns year ago 
    * Announces progress in the bile duct study, with potential to progress into 
Phase II in first half of 2016 
 
     
Source text for Eikon:  ID:nHUG40vS8W  
     
Further company coverage:  PCIB.OL  
 
($1 = 8.7062 Norwegian crowns) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))